Detalhe da pesquisa
1.
Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study.
Haemophilia
; 28(1): 46-54, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791736
2.
The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A.
Blood Adv
; 7(4): 620-629, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858373
3.
Safety and effectiveness of recombinant factor XIII-A2 in congenital factor XIII deficiency: Real-world evidence.
Res Pract Thromb Haemost
; 6(2): e12628, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243202